Catalog number,old,MW,Plate Location,Plate number,96 Plate Map,96 well,384 Plate ID,Plate Map,Well,Human Readable Name,Plate description,Concentration,Compound description,Solvent,Plate part number,MoleculeID
EI-126,Dexamethasone,392.5,5-A09,5,Plate 1,A09,EnzoICCB2,SP0130,A17,Dexamethasone - steroid hormone,ICCB Known Bioactives Library,2.55,Nuclear receptor ligands:  corticosteroid,DMSO,2840,Dexamethasone - steroid hormone
GR-311,Mitomycin C,334.3,5-H05,5,Plate 1,H05,EnzoICCB2,SP0130,O09,Mitomycin C - Inhibits DNA synthesis,ICCB Known Bioactives Library,2.99,Inhibitors:  cross links DNA,DMSO,2840,Mitomycin C - Inhibits DNA synthesis
CC-103,Methotrexate,424.5,5-H02,5,Plate 1,H02,EnzoICCB2,SP0130,O03,Methotrexate - DHFR inhibitor,ICCB Known Bioactives Library,2.36,CNS receptor ligands:  DHFR inhibitor,DMSO,2840,Methotrexate - DHFR inhibitor
EI-270,Rottlerin,516.5,6-C11,6,Plate 2,C11,EnzoICCB2,SP0130,E22,Rottlerin - kinase inhibitor,ICCB Known Bioactives Library,1.94,Kinase inhibitors:  PKC delta inhibitor,DMSO,2840,Rottlerin - kinase inhibitor
A-230,Decoyinine,279.3,5-A06,5,Plate 1,A06,EnzoICCB2,SP0130,A11,Decoyinine - GMP synthetase inhibitor,ICCB Known Bioactives Library,3.58,Inhibitors:  lowers GTP levels,DMSO,2840,Decoyinine - GMP synthetase inhibitor
AR-107,(S)-(-)-propranolol·HCl,295.8,6-B11,6,Plate 2,B11,EnzoICCB2,SP0130,C22,Propranolol (S-) - beta adrenergic agonist,ICCB Known Bioactives Library,3.38,CNS receptor ligands:  adrenoceptor antagonist (beta),DMSO,2840,Propranolol (S-) - beta adrenergic agonist
EI-306,SU-4312,264.3,6-A10,6,Plate 2,A10,EnzoICCB2,SP0130,A20,SU-4312 - kinase inhibitor,ICCB Known Bioactives Library,3.78,Kinase inhibitors:  VEGF-R (Flk-1) tyrosine kinase ,DMSO,2840,SU-4312 - kinase inhibitor
AP-300,TPEN,424.5,6-F04,6,Plate 2,F04,EnzoICCB2,SP0130,K08,TPEN - cell permable heavy metal chelator,ICCB Known Bioactives Library,2.36,Inhibitors:  cell permable heavy metal chelator,DMSO,2840,TPEN - cell permable heavy metal chelator
PI-120,Pepstatin,685.9,6-A11,6,Plate 2,A11,EnzoICCB2,SP0130,A22,Pepstatin - protease inhibitor,ICCB Known Bioactives Library,1.46,Protease inhibitors:  protease inhibitor,DMSO,2840,Pepstatin - protease inhibitor
T-112,Alrestatin,255.2,6-E03,6,Plate 2,E03,EnzoICCB2,SP0130,I06,Alrestatin - aldose reductase inhibitor,ICCB Known Bioactives Library,3.92,Inhibitors:  aldose reductase inhibitor,DMSO,2840,Alrestatin - aldose reductase inhibitor
PI-143,Nafamostat mesylate ,443.5,6-F08,6,Plate 2,F08,EnzoICCB2,SP0130,K16,Nafamostst mesylate - protease inhibitor,ICCB Known Bioactives Library,2.25,Inhibitors:  Serine protease inhibitor,DMSO,2840,Nafamostst mesylate - protease inhibitor
ST-300,RHC-80267,394.5,6-C08,6,Plate 2,C08,EnzoICCB2,SP0130,E16,RHC-80267 - DAG lipase inhibitor,ICCB Known Bioactives Library,2.53,Lipid biosynthesis:  DAG lipase inhibitor,DMSO,2840,RHC-80267 - DAG lipase inhibitor
PI-107,E-64-d,342.4,5-B11,5,Plate 1,B11,EnzoICCB2,SP0130,C21,E-64-d - protease inhibitor,ICCB Known Bioactives Library,2.92,Protease inhibitors:  calpain/cathepsin inhibitor,DMSO,2840,E-64-d - protease inhibitor
EI-184,HA-1004,293.3,5-D08,5,Plate 1,D08,EnzoICCB2,SP0130,G15,HA-1004 - kinase inhibitor,ICCB Known Bioactives Library,3.41,Kinase inhibitors:  kinase inhibitor,DMSO,2840,HA-1004 - kinase inhibitor
A-235,FK-506,804,5-H11,5,Plate 1,H11,EnzoICCB2,SP0130,O21,FK-506 - prolyl cis-trans isomerase inhibitor,ICCB Known Bioactives Library,1.24,Inhibitors:  FKBP ligand,DMSO,2840,FK-506 - prolyl cis-trans isomerase inhibitor
EI-261,NS-398,314.4,6-H03,6,Plate 2,H03,EnzoICCB2,SP0130,O06,NS-398 - cyclooxygenase inhibitor,ICCB Known Bioactives Library,3.18,Lipid biosynthesis:  Cox-2 inhibitor,DMSO,2840,NS-398 - cyclooxygenase inhibitor
EI-211,CDC,321.3,6-H08,6,Plate 2,H08,EnzoICCB2,SP0130,O16,CDC - lipoxygenase inhibitor,ICCB Known Bioactives Library,3.11,Lipid biosynthesis:  12-Lipoxygenase inhibitor,DMSO,2840,CDC - lipoxygenase inhibitor
EI-271,Piceatannol,244.2,6-D11,6,Plate 2,D11,EnzoICCB2,SP0130,G22,Piceatannol - kinase inhibitor,ICCB Known Bioactives Library,4.09,Kinase inhibitors:  Syk inhibitor,DMSO,2840,Piceatannol - kinase inhibitor
AP-100,6(5H)-Phenanthridinone,195.2,6-B02,6,Plate 2,B02,EnzoICCB2,SP0130,C04,Phenanthridinone [6(5H)-Phenanthridinone] - PARP inhibitor,ICCB Known Bioactives Library,5.12,Inhibitors:  PARP inhibitor,DMSO,2840,Phenanthridinone [6(5H)-Phenanthridinone] - PARP inhibitor
CC-200,Olomoucine,298.3,6-A06,6,Plate 2,A06,EnzoICCB2,SP0130,A12,Olomoucine - kinase inhibitor,ICCB Known Bioactives Library,3.35,Kinase inhibitors:  CDK inhibitor,DMSO,2840,Olomoucine - kinase inhibitor
CN-240,Diphenyleneiodonium ,279.1,5-B05,5,Plate 1,B05,EnzoICCB2,SP0130,C09,Diphenyleneiodonium Cl - NOS inhibitor,ICCB Known Bioactives Library,3.58,Inhibitors:  flavoprotein inhibitor,DMSO,2840,Diphenyleneiodonium Cl - NOS inhibitor
C-117,(-)-Huperzine A,242.3,5-E03,5,Plate 1,E03,EnzoICCB2,SP0130,I05,Huperzine A [(-)-Huperzine A] - acetylcholinesterase inhibitor,ICCB Known Bioactives Library,4.13,Inhibitors:  acetylcholinesterase inhibitor,DMSO,2840,Huperzine A [(-)-Huperzine A] - acetylcholinesterase inhibitor
PI-118,Leupeptin,426.6,5-F09,5,Plate 1,F09,EnzoICCB2,SP0130,K17,Leupeptin - protease inhibitor,ICCB Known Bioactives Library,2.34,Protease inhibitors:  protease inhibitor,DMSO,2840,Leupeptin - protease inhibitor
EI-233,HA1077,364.3,5-D07,5,Plate 1,D07,EnzoICCB2,SP0130,G13,HA1077 - kinase inhibitor,ICCB Known Bioactives Library,2.75,Kinase inhibitors:  inhibitor of Rho-dependent kinases,DMSO,2840,HA1077 - kinase inhibitor
EI-215,tyrphostin 9,282.4,6-F11,6,Plate 2,F11,EnzoICCB2,SP0130,K22,Tyrphostin 9 - kinase inhibitor,ICCB Known Bioactives Library,3.54,Kinase inhibitors:  PDGF-R tyrosine kinase inhibitor,DMSO,2840,Tyrphostin 9 - kinase inhibitor
EI-153,ML9,324.8,5-H07,5,Plate 1,H07,EnzoICCB2,SP0130,O13,ML9 - kinase,ICCB Known Bioactives Library,3.08,Kinase inhibitors:  kinase inhibitor,DMSO,2840,ML9 - kinase
EI-199,KT-5720,423.5,5-F03,5,Plate 1,F03,EnzoICCB2,SP0130,K05,KT-5720 - kinase inhibitor,ICCB Known Bioactives Library,0.236,Kinase inhibitors:  PKA inhibitor,DMSO,2840,KT-5720 - kinase inhibitor
EI-197,ML7,416.3,5-H06,5,Plate 1,H06,EnzoICCB2,SP0130,O11,ML7 - kinase inhibitor,ICCB Known Bioactives Library,2.4,Kinase inhibitors:  kinase inhibitor,DMSO,2840,ML7 - kinase inhibitor
CM-109,Ouabain,584.7,6-A07,6,Plate 2,A07,EnzoICCB2,SP0130,A14,Ouabain - Na+K+ATPase inhibitor,ICCB Known Bioactives Library,1.71,Inhibitors:  Na+K+ATPase inhibitor,DMSO,2840,Ouabain - Na+K+ATPase inhibitor
CC-104,tunicamycin,718.7,6-F07,6,Plate 2,F07,EnzoICCB2,SP0130,K14,Tunicamycin - protein glycosylation inhibitor,ICCB Known Bioactives Library,1.39,Inhibitors:  glycosylation inhibitor,DMSO,2840,Tunicamycin - protein glycosylation inhibitor
ST-391,U73122,464.6,6-G02,6,Plate 2,G02,EnzoICCB2,SP0130,M04,U73122 - phospholipase inhibitor,ICCB Known Bioactives Library,2.15,Lipid biosynthesis:  PLC inhibitor,DMSO,2840,U73122 - phospholipase inhibitor
EI-195,H9,324.2,5-D06,5,Plate 1,D06,EnzoICCB2,SP0130,G11,H9 - kinase inhibitor,ICCB Known Bioactives Library,3.08,Kinase inhibitors:  kinase inhibitor,DMSO,2840,H9 - kinase inhibitor
EI-185,Lavendustin A,381.4,5-F07,5,Plate 1,F07,EnzoICCB2,SP0130,K13,Lavendustin A - kinase inhibitor,ICCB Known Bioactives Library,2.62,Kinase inhibitors:  Tyrosine kinase inhibitor EGF-R),DMSO,2840,Lavendustin A - kinase inhibitor
EI-230,KN-62,721.8,5-F02,5,Plate 1,F02,EnzoICCB2,SP0130,K03,KN-62 - kinase inhibitor,ICCB Known Bioactives Library,1.39,Kinase inhibitors:  CaM kinase II inhibitor,DMSO,2840,KN-62 - kinase inhibitor
EI-196,H-89,446.4,5-D05,5,Plate 1,D05,EnzoICCB2,SP0130,G09,H-89 - kinase inhibitor,ICCB Known Bioactives Library,2.24,Kinase inhibitors:  PKA inhibitor,DMSO,2840,H-89 - kinase inhibitor
EI-305,SP-600125,220.2,6-C04,6,Plate 2,C04,EnzoICCB2,SP0130,E08,SP-600125 - kinase inhibitor,ICCB Known Bioactives Library,4.54,Kinase inhibitors:  JNK inhibitor,DMSO,2840,SP-600125 - kinase inhibitor
EI-246,GF-109203X,412.5,6-E11,6,Plate 2,E11,EnzoICCB2,SP0130,I22,GF-109203X - kinase inhibitor,ICCB Known Bioactives Library,2.42,Kinase inhibitors:  PKC inhibitor,DMSO,2840,GF-109203X - kinase inhibitor
EI-253,RG-14620,275.1,6-E08,6,Plate 2,E08,EnzoICCB2,SP0130,I16,RG-14620 - kinase inhibitor,ICCB Known Bioactives Library,3.63,Kinase inhibitors:  EGF-R tyrosine kinase inhibitor,DMSO,2840,RG-14620 - kinase inhibitor
EI-283,Ro 31-8220,457.5,5-C10,5,Plate 1,C10,EnzoICCB2,SP0130,E19,Ro 31-8220 - kinase inhibitor,ICCB Known Bioactives Library,2.19,Kinase inhibitors:  PKC inhibitor,DMSO,2840,Ro 31-8220 - kinase inhibitor
C-114,(+/-)-Epibatidine,208.7,5-H03,5,Plate 1,H03,EnzoICCB2,SP0130,O05,Epibatidine (+/-) - nicotinic cholinergic agonist,ICCB Known Bioactives Library,4.79,CNS receptor ligands:  nicotinic cholinergic agonist,DMSO,2840,Epibatidine (+/-) - nicotinic cholinergic agonist
T-116,vinblastine,909.1,6-G05,6,Plate 2,G05,EnzoICCB2,SP0130,M10,Vinblastine - microtubule poison,ICCB Known Bioactives Library,1.1,Inhibitors:  tubulin inhibitor,DMSO,2840,Vinblastine - microtubule poison
S-620,Pregnenolone-16?-carbonitrile,341.5,5-C03,5,Plate 1,C03,EnzoICCB2,SP0130,E05,Pregnenolone 16? carbonitrile - steroid hormone,ICCB Known Bioactives Library,2.93,Nuclear receptor ligands:  PXR/SXR agonist,DMSO,2840,Pregnenolone 16? carbonitrile - steroid hormone
AC-161,yohimbine,390.9,6-G09,6,Plate 2,G09,EnzoICCB2,SP0130,M18,Yohimbine - alpha adrenergic antagonist,ICCB Known Bioactives Library,2.56,CNS receptor ligands:  Adrenoreceptor antagonist (alpha),DMSO,2840,Yohimbine - alpha adrenergic antagonist
EI-299,Y-27632,247.3,6-G08,6,Plate 2,G08,EnzoICCB2,SP0130,M16,Y-27632 - kinase inhibitor,ICCB Known Bioactives Library,4.04,Kinase inhibitors:  ROCK inhibitor,DMSO,2840,Y-27632 - kinase inhibitor
EI-286,SB 203580,377.4,6-D03,6,Plate 2,D03,EnzoICCB2,SP0130,G06,SB 203580 - kinase inhibitor,ICCB Known Bioactives Library,2.65,Kinase inhibitors:  Suppressor of MAPKAP kinase-2,DMSO,2840,SB 203580 - kinase inhibitor
NS-820,serotonin,176.2,6-D07,6,Plate 2,D07,EnzoICCB2,SP0130,G14,Serotonin - serotonin receptor agonist,ICCB Known Bioactives Library,5.67,CNS receptor ligands:  serotonin receptor agonist,DMSO,2840,Serotonin - serotonin receptor agonist
ST-420,LY-294002,307.3,5-G03,5,Plate 1,G03,EnzoICCB2,SP0130,M05,LY-294002 - kinase,ICCB Known Bioactives Library,3.25,Lipid biosynthesis:  PI-3-Kinase inhibitor,DMSO,2840,LY-294002 - kinase
PR-112,RK-682,368.5,6-C09,6,Plate 2,C09,EnzoICCB2,SP0130,E18,RK-682 - phosphatase inhibitor,ICCB Known Bioactives Library,2.71,Inhibitors:  VHR phosphatase inhibitor,DMSO,2840,RK-682 - phosphatase inhibitor
CN-257,Thiocitrulline [L-Thiocitrulline],191.3,6-E10,6,Plate 2,E10,EnzoICCB2,SP0130,I20,Thiocitrulline [L-Thiocitrulline HCl] - NOS inhibitor,ICCB Known Bioactives Library,5.23,Inhibitors:  bNOS inhibitor,DMSO,2840,Thiocitrulline [L-Thiocitrulline HCl] - NOS inhibitor
PE-160,Phorbol 12-myristate 13-acetate,616.8,6-B03,6,Plate 2,B03,EnzoICCB2,SP0130,C06,Phorbol 12 myristate 13 acetate - PKC activator,ICCB Known Bioactives Library,1.62,Activators:  PKC activator,DMSO,2840,Phorbol 12 myristate 13 acetate - PKC activator
EI-360,PD 98059,267.3,6-A09,6,Plate 2,A09,EnzoICCB2,SP0130,A18,PD 98059 - kinase inhibitor,ICCB Known Bioactives Library,3.74,Kinase inhibitors:  MEK inhibitor,DMSO,2840,PD 98059 - kinase inhibitor
CN-125,Dibutyrylcyclic AMP,491.4,5-A10,5,Plate 1,A10,EnzoICCB2,SP0130,A19,Dibutyrylcyclic AMP - PKA activator,ICCB Known Bioactives Library,2.04,Activators:  PKA activator,DMSO,2840,Dibutyrylcyclic AMP - PKA activator
CN-140,SQ22536,205.2,6-E02,6,Plate 2,E02,EnzoICCB2,SP0130,I04,SQ22536 - adenylate cyclase inhibitor,ICCB Known Bioactives Library,4.87,Inhibitors:  adenylate cyclase inhibitor,DMSO,2840,SQ22536 - adenylate cyclase inhibitor
G-237,Cerulenin,223.3,6-H09,6,Plate 2,H09,EnzoICCB2,SP0130,O18,Cerulenin - Fatty acid biosynthesis inhibitor,ICCB Known Bioactives Library,4.48,Lipid biosynthesis:  Fatty acid biosynthesis inhibitor,DMSO,2840,Cerulenin - Fatty acid biosynthesis inhibitor
CC-205,Roscovitine,354.4,6-C10,6,Plate 2,C10,EnzoICCB2,SP0130,E20,Roscovitine - kinase inhibitor,ICCB Known Bioactives Library,2.82,Kinase inhibitors:  CDK inhibitor,DMSO,2840,Roscovitine - kinase inhibitor
S-110,1-Deoxynojirimycin,163.2,5-A08,5,Plate 1,A08,EnzoICCB2,SP0130,A15,Deoxynorjrimycin(1) - glycoside hydrolase inhibitor,ICCB Known Bioactives Library,6.13,Inhibitors:  glucosidase inhibitor,DMSO,2840,Deoxynorjrimycin(1) - glycoside hydrolase inhibitor
AC-146,Prazocin,383.4,6-B09,6,Plate 2,B09,EnzoICCB2,SP0130,C18,Prazocin - alpha adrenergic agonist,ICCB Known Bioactives Library,2.61,CNS receptor ligands:  adrenoreceptor agonist,DMSO,2840,Prazocin - alpha adrenergic agonist
ST-415,wortmannin,428.4,6-G07,6,Plate 2,G07,EnzoICCB2,SP0130,M14,Wortmannin - kinase inhibitor,ICCB Known Bioactives Library,2.33,Lipid biosynthesis:  PI-3Kinase; other kinases inhibitor,DMSO,2840,Wortmannin - kinase inhibitor
EI-278,BAY 11-7082,207.2,5-F10,5,Plate 1,F10,EnzoICCB2,SP0130,K19,Bay 11-7082 - kinase inhibitor,ICCB Known Bioactives Library,4.83,Inhibitors:  Inhibits IKK kinase activation,DMSO,2840,Bay 11-7082 - kinase inhibitor
KC-140,valinomycin,1111.3,6-G04,6,Plate 2,G04,EnzoICCB2,SP0130,M08,Valinomycin - K+ ionophore,ICCB Known Bioactives Library,0.9,Ion channel ligands:  K+ ionophore,DMSO,2840,Valinomycin - K+ ionophore
GR-332,ICRF-193,282.3,5-E05,5,Plate 1,E05,EnzoICCB2,SP0130,I09,ICRF-193 - Inhibits DNA synthesis,ICCB Known Bioactives Library,3.54,Inhibitors:  topo II inhibitor that does not cause DNA breaks,DMSO,2840,ICRF-193 - Inhibits DNA synthesis
EI-307,GW-5074,520.9,5-H09,5,Plate 1,H09,EnzoICCB2,SP0130,O17,GW-5074 - kinase inhibitor,ICCB Known Bioactives Library,1.92,Kinase inhibitors:  cRAF1 kinase inhibitor,DMSO,2840,GW-5074 - kinase inhibitor
T-109,Cytochalasin D,507.6,5-A02,5,Plate 1,A02,EnzoICCB2,SP0130,A03,Cytochalasin D - actin poison,ICCB Known Bioactives Library,1.97,Inhibitors:  F actin capper,DMSO,2840,Cytochalasin D - actin poison
A-248,Monensin,692.9,5-H10,5,Plate 1,H10,EnzoICCB2,SP0130,O19,Monensin - Na+ ionophore,ICCB Known Bioactives Library,1.44,Ion channel ligands:  Na+ ionophore,DMSO,2840,Monensin - Na+ ionophore
GR-234,GW-9662,276.7,5-B02,5,Plate 1,B02,EnzoICCB2,SP0130,C03,GW-9662 - PPAR ligand,ICCB Known Bioactives Library,3.61,Nuclear receptor ligands:  PPAR gamma antagonist,DMSO,2840,GW-9662 - PPAR ligand
GR-303,Hoechst  33342·3HCl (BisBenzimide),561.9,5-E02,5,Plate 1,E02,EnzoICCB2,SP0130,I03,Hoechst  33342 (cell permeable) (BisBenzimide) - DNA binding,ICCB Known Bioactives Library,1.78,Inhibitors:  DNA minor groove binder,DMSO,2840,Hoechst  33342 (cell permeable) (BisBenzimide) - DNA binding
A-249,Mycophenolic acid,290.4,6-H05,6,Plate 2,H05,EnzoICCB2,SP0130,O10,Mycophenolic acid - Inhibits DNA synthesis,ICCB Known Bioactives Library,3.44,Inhibitors:  Inosine-5'-monophosphate dehydrogenase inhibitor,DMSO,2840,Mycophenolic acid - Inhibits DNA synthesis
EI-293,5-Iodotubercidin,392.1,5-G05,5,Plate 1,G05,EnzoICCB2,SP0130,M09,5-Iodotubercidin - kinase inhibitor,ICCB Known Bioactives Library,2.55,Kinase inhibitors:  ERK-2 inhibitor,DMSO,2840,5-Iodotubercidin - kinase inhibitor
GR-319,Doxorubicin,580,5-B07,5,Plate 1,B07,EnzoICCB2,SP0130,C13,Doxorubicin - Inhibits DNA synthesis,ICCB Known Bioactives Library,1.72,Inhibitors:  topoisomerase II inhibitor; induces apoptosis,DMSO,2840,Doxorubicin - Inhibits DNA synthesis
AP-401,Propidium iodide,668.4,6-B10,6,Plate 2,B10,EnzoICCB2,SP0130,C20,Propidium iodide - DNA binding,ICCB Known Bioactives Library,1.5,Inhibitors:  DNA intercalator,DMSO,2840,Propidium iodide - DNA binding
EI-190,tyrphostin 1,184.2,6-F10,6,Plate 2,F10,EnzoICCB2,SP0130,K20,Tyrphostin 1 - phosphatase inhibitor,ICCB Known Bioactives Library,5.43,Inhibitors:  Calcineurin inhibitor,DMSO,2840,Tyrphostin 1 - phosphatase inhibitor
PD-140,IBMX,222.2,5-E08,5,Plate 1,E08,EnzoICCB2,SP0130,I15,IBMX - phosphodiesterase inhibitor,ICCB Known Bioactives Library,4.5,Inhibitors:  PDE inhibitor (broad spec); adenosineR agonist,DMSO,2840,IBMX - phosphodiesterase inhibitor
EI-314,SB-431542,384.4,6-C03,6,Plate 2,C03,EnzoICCB2,SP0130,E06,SB-431542 - kinase inhibitor,ICCB Known Bioactives Library,2.6,Kinase inhibitors:  ALK4; ALK5; ALK7 inhibitor,DMSO,2840,SB-431542 - kinase inhibitor
EI-280,Geldanamycin,560.6,5-C08,5,Plate 1,C08,EnzoICCB2,SP0130,E15,Geldanamycin - HSP-90 inhibitor,ICCB Known Bioactives Library,1.78,Inhibitors:  HSP90 inhibitor,DMSO,2840,Geldanamycin - HSP-90 inhibitor
T-101,Nocodazole,301.3,6-A02,6,Plate 2,A02,EnzoICCB2,SP0130,A04,Nocodazole - microtubule poison,ICCB Known Bioactives Library,3.32,Inhibitors:  tubulin inhibitor,DMSO,2840,Nocodazole - microtubule poison
T-104,taxol = paclitaxel,853.9,6-E07,6,Plate 2,E07,EnzoICCB2,SP0130,I14,Taxol = Paclitaxel - microtubule poison,ICCB Known Bioactives Library,1.17,Inhibitors:  microtubule stabilizer,DMSO,2840,Taxol = Paclitaxel - microtubule poison
GR-307,Etoposide,588.6,5-C05,5,Plate 1,C05,EnzoICCB2,SP0130,E09,Etoposide - Inhibits DNA synthesis,ICCB Known Bioactives Library,1.7,Inhibitors:  topoisomerase II inhibitor,DMSO,2840,Etoposide - Inhibits DNA synthesis
EI-219,Piroxicam,331.3,6-B06,6,Plate 2,B06,EnzoICCB2,SP0130,C12,Piroxicam - cyclooxygenase inhibitor,ICCB Known Bioactives Library,3.02,Lipid biosynthesis:  COX1 inhibitor,DMSO,2840,Piroxicam - cyclooxygenase inhibitor
CM-120,FCCP,254.2,5-C06,5,Plate 1,C06,EnzoICCB2,SP0130,E11,FCCP - mitochondrial uncoupler,ICCB Known Bioactives Library,3.93,Inhibitors:  mitochondrial uncoupler,DMSO,2840,FCCP - mitochondrial uncoupler
CA-310,trifluoperazine,480.4,6-F06,6,Plate 2,F06,EnzoICCB2,SP0130,K12,Trifluoperazine - dopamine antagonist,ICCB Known Bioactives Library,2.08,Inhibitors:  calmodulin inhibitor-possibly only at high concentrations!,DMSO,2840,Trifluoperazine - dopamine antagonist
GR-334,Cyclopamine,411.6,6-B07,6,Plate 2,B07,EnzoICCB2,SP0130,C14,Cyclopamine - Hedgehog pathway inhibitor,ICCB Known Bioactives Library,2.43,Inhibitors:  Hedgehog pathway inhibitor,DMSO,2840,Cyclopamine - Hedgehog pathway inhibitor
EI-147,Genistein,260.4,5-C09,5,Plate 1,C09,EnzoICCB2,SP0130,E17,Genistein - kinase inhibitor,ICCB Known Bioactives Library,3.84,Kinase inhibitors:  Tyrosine kinase inhibitor,DMSO,2840,Genistein - kinase inhibitor
EI-274,Damnacanthal,282.2,5-A04,5,Plate 1,A04,EnzoICCB2,SP0130,A07,Damnacanthal - kinase inhibitor,ICCB Known Bioactives Library,3.54,Kinase inhibitors:  p56lck inhibitor,DMSO,2840,Damnacanthal - kinase inhibitor
CC-206,Indirubin,262.3,6-D06,6,Plate 2,D06,EnzoICCB2,SP0130,G12,Indirubin - kinase inhibitor,ICCB Known Bioactives Library,3.81,Kinase inhibitors:  GSK-3beta inhibitor,DMSO,2840,Indirubin - kinase inhibitor
BL-169,Juglone,174.2,5-E10,5,Plate 1,E10,EnzoICCB2,SP0130,I19,Juglone - PIN1 inhibitor,ICCB Known Bioactives Library,5.74,Inhibitors:  PIN1 inhibitor,DMSO,2840,Juglone - PIN1 inhibitor
FR-110,Hinokitiol,164.2,5-B04,5,Plate 1,B04,EnzoICCB2,SP0130,C07,Hinokitiol - iron chelator,ICCB Known Bioactives Library,6.09,Inhibitors:  Iron chelator,DMSO,2840,Hinokitiol - iron chelator
BL-093,Estradiol,272.4,5-C04,5,Plate 1,C04,EnzoICCB2,SP0130,E07,Estradiol - microtubule poison,ICCB Known Bioactives Library,3.67,Nuclear receptor ligands:  estrogen,DMSO,2840,Estradiol - microtubule poison
T-115,thalidomide,258.2,6-E09,6,Plate 2,E09,EnzoICCB2,SP0130,I18,Thalidomide - inhibits ubiquitin ligase activity,ICCB Known Bioactives Library,3.87,Inhibitors:  TNFalpha synthesis inhibitor,DMSO,2840,Thalidomide - inhibits ubiquitin ligase activity
NA-136,Kavain (+/-),230.3,6-F03,6,Plate 2,F03,EnzoICCB2,SP0130,K06,Kavain (+/-) - voltage-dependent Na channel inhibitor,ICCB Known Bioactives Library,4.34,Ion channel ligands:  voltage-dependent Na channel inhibitor,DMSO,2840,Kavain (+/-) - voltage-dependent Na channel inhibitor
FR-104,resveratrol,228.2,6-D08,6,Plate 2,D08,EnzoICCB2,SP0130,G16,Resveratrol - SIRT1 activator,ICCB Known Bioactives Library,4.38,Activators:  SIRT1 activator,DMSO,2840,Resveratrol - SIRT1 activator
AC-764,Histamine,111.1,5-D10,5,Plate 1,D10,EnzoICCB2,SP0130,G19,Histamine - histamine receptor ligand,ICCB Known Bioactives Library,9,CNS receptor ligands:  Histamine receptor agonist,DMSO,2840,Histamine - histamine receptor ligand
CN-215,Dibutyrylcyclic GMP,485.4,5-A11,5,Plate 1,A11,EnzoICCB2,SP0130,A21,Dibutyrylcyclic GMP - PKA activator,ICCB Known Bioactives Library,2.06,Activators:  PKA activator,DMSO,2840,Dibutyrylcyclic GMP - PKA activator
CN-242,L-NAME,233.2,5-G02,5,Plate 1,G02,EnzoICCB2,SP0130,M03,L-NAME - NOS inhibitor,ICCB Known Bioactives Library,4.29,Inhibitors:  NO synthesis inhibitor,DMSO,2840,L-NAME - NOS inhibitor
PD-129,EHNA ,277.4,5-C02,5,Plate 1,C02,EnzoICCB2,SP0130,E03,EHNA HCl - phosphodiesterase inhibitor,ICCB Known Bioactives Library,3.61,Inhibitors:  Phosphodiesterase (PDE2) inhibitor/adenosine deaminase inhibitor,DMSO,2840,EHNA HCl - phosphodiesterase inhibitor
CT-115,Shikonin,288.3,6-H06,6,Plate 2,H06,EnzoICCB2,SP0130,O12,Shikonin - protease inhibitor,ICCB Known Bioactives Library,3.47,Inhibitors:  Apoptosis inducer; p53 dependent,DMSO,2840,Shikonin - protease inhibitor
EI-287,Nimesulide,308.3,5-D03,5,Plate 1,D03,EnzoICCB2,SP0130,G05,Nimesulide - cyclooxygenase inhibitor,ICCB Known Bioactives Library,3.24,Lipid biosynthesis:  Cox 2 inhibitor,DMSO,2840,Nimesulide - cyclooxygenase inhibitor
AC-1557,2-APB,225.1,6-H07,6,Plate 2,H07,EnzoICCB2,SP0130,O14,2-APB - IP3 receptor blocker,ICCB Known Bioactives Library,4.44,Inhibitors:  IP3 receptor blocker,DMSO,2840,2-APB - IP3 receptor blocker
G-236,Manumycin A,550.6,5-G07,5,Plate 1,G07,EnzoICCB2,SP0130,M13,Manumycin A - farnesylation inhibitor,ICCB Known Bioactives Library,1.82,Inhibitors:  ras farnesylation inhibitor,DMSO,2840,Manumycin A - farnesylation inhibitor
EI-231,DRB (Benzimidazole),319.1,5-B08,5,Plate 1,B08,EnzoICCB2,SP0130,C15,DRB - kinase inhibitor,ICCB Known Bioactives Library,3.13,Kinase inhibitors:  CKII inhibitor,DMSO,2840,DRB - kinase inhibitor
EI-131,Indomethacin,357.8,5-E06,5,Plate 1,E06,EnzoICCB2,SP0130,I11,Indomethacin - cyclooxygenase inhibitor,ICCB Known Bioactives Library,2.79,Lipid biosynthesis:  cyclooxygenase inhibitor,DMSO,2840,Indomethacin - cyclooxygenase inhibitor
A-275,Rapamycin,914.2,6-C06,6,Plate 2,C06,EnzoICCB2,SP0130,E12,Rapamycin - prolyl cis-trans isomerase inhibitor,ICCB Known Bioactives Library,1.09,Inhibitors:  FRAP inhibitor ,DMSO,2840,Rapamycin - prolyl cis-trans isomerase inhibitor
S-650,tamoxifen,371.5,6-E06,6,Plate 2,E06,EnzoICCB2,SP0130,I12,Tamoxifen - estrogen antagonist,ICCB Known Bioactives Library,2.69,Nuclear receptor ligands:  estrogen antagonist,DMSO,2840,Tamoxifen - estrogen antagonist
CA-201,Ionomycin,679,5-E07,5,Plate 1,E07,EnzoICCB2,SP0130,I13,Ionomycin - Calcium ionophore,ICCB Known Bioactives Library,1.47,Ion channel ligands:  Ca++ ionophore,DMSO,2840,Ionomycin - Calcium ionophore
CM-111,Oligomycin A,791.1,6-A05,6,Plate 2,A05,EnzoICCB2,SP0130,A10,Oligomycin A - Fo ATP synthase inhibitor,ICCB Known Bioactives Library,1.26,Inhibitors:  Fo ATP synthase inhibitor ,DMSO,2840,Oligomycin A - Fo ATP synthase inhibitor
GR-312,Puromycin·2HCl,530.4,6-C02,6,Plate 2,C02,EnzoICCB2,SP0130,E04,Puromycin - inhibits protein synthesis,ICCB Known Bioactives Library,1.89,Inhibitors:  protein synthesis inhibitor,DMSO,2840,Puromycin - inhibits protein synthesis
GR-309,trichostatin-A,302.4,6-F05,6,Plate 2,F05,EnzoICCB2,SP0130,K10,Trichostatin-A - histone deacetylase inhibitor,ICCB Known Bioactives Library,3.31,Inhibitors:  histone deacetylase inhibitor,DMSO,2840,Trichostatin-A - histone deacetylase inhibitor
AC-1142,Quercetin·2H2O,338.3,6-C05,6,Plate 2,C05,EnzoICCB2,SP0130,E10,Quercetin - kinase inhibitor,ICCB Known Bioactives Library,2.96,Kinase inhibitors:  kinase inhibitor (plus other),DMSO,2840,Quercetin - kinase inhibitor
CA-320,W7,377.3,6-G06,6,Plate 2,G06,EnzoICCB2,SP0130,M12,W7 - calmodulin inhibitor,ICCB Known Bioactives Library,2.65,Inhibitors:  calmodulin antagonist,DMSO,2840,W7 - calmodulin inhibitor
EI-156,staurosporine,466.5,6-E04,6,Plate 2,E04,EnzoICCB2,SP0130,I08,Staurosporine - kinase inhibitor,ICCB Known Bioactives Library,2.14,Kinase inhibitors:  kinase inhibitor - non-selective,DMSO,2840,Staurosporine - kinase inhibitor
CA-305,Phenoxybenzamine,303.8,6-H10,6,Plate 2,H10,EnzoICCB2,SP0130,O20,Phenoxybenzamine - calmodulin inhibitor,ICCB Known Bioactives Library,3.29,Inhibitors:  Calmodulin antagonist,DMSO,2840,Phenoxybenzamine - calmodulin inhibitor
GR-325,Pifithrin-?,286.4,6-B04,6,Plate 2,B04,EnzoICCB2,SP0130,C08,Pifithrin - p53 inhibitor,ICCB Known Bioactives Library,3.49,Inhibitors:  p53 inhibitor,DMSO,2840,Pifithrin - p53 inhibitor
CN-100,Forskolin,410.5,5-C07,5,Plate 1,C07,EnzoICCB2,SP0130,E13,Forskolin - adenylate cyclase activator,ICCB Known Bioactives Library,2.44,Activators:  Adenylate cyclase activator,DMSO,2840,Forskolin - adenylate cyclase activator
PI-129 ,Gliotoxin,326.4,5-G10,5,Plate 1,G10,EnzoICCB2,SP0130,M19,Gliotoxin - protease inhibitor,ICCB Known Bioactives Library,3.06,Protease inhibitors:  Inhibitor of 20S-proteasome chymotrypsin activity,DMSO,2840,Gliotoxin - protease inhibitor
G-410,Mastoparan,1688.6,5-G08,5,Plate 1,G08,EnzoICCB2,SP0130,M15,Mastoparan - activates heterotrimeriuc GTPases,ICCB Known Bioactives Library,0.592,Activators:  activates heterotrimeriuc GTPases,DMSO,2840,Mastoparan - activates heterotrimeriuc GTPases
S-112,swainsonine,173.2,6-E05,6,Plate 2,E05,EnzoICCB2,SP0130,I10,Swainsonine - protein glycosylation inhibitor,ICCB Known Bioactives Library,5.77,Inhibitors:  protein glycosylation inhibitor,DMSO,2840,Swainsonine - protein glycosylation inhibitor
D-100,6;7-ADTN ,179.2,5-B03,5,Plate 1,B03,EnzoICCB2,SP0130,C05,6;7-ADTN HBr - dopamine antagonist,ICCB Known Bioactives Library,5.58,CNS receptor ligands:  Dopamine agonist,DMSO,2840,6;7-ADTN HBr - dopamine antagonist
EI-177,Manoalide,416.6,5-G06,5,Plate 1,G06,EnzoICCB2,SP0130,M11,Manoalide - phospholipase inhibitor,ICCB Known Bioactives Library,2.4,Lipid biosynthesis:  Phospholipase A2 inhibitor,DMSO,2840,Manoalide - phospholipase inhibitor
G-226,Mevinolin (Lovastatin),404.5,5-H04,5,Plate 1,H04,EnzoICCB2,SP0130,O07,Mevinolin (Lovastatin) - Inhibitor HMG-CoA reductase,ICCB Known Bioactives Library,2.47,Lipid biosynthesis:  Inhibitor HMG-CoA reductase,DMSO,2840,Mevinolin (Lovastatin) - Inhibitor HMG-CoA reductase
T-110,Latrunculin B,395.5,5-F06,5,Plate 1,F06,EnzoICCB2,SP0130,K11,Latrunculin B - actin poison,ICCB Known Bioactives Library,2.53,Inhibitors:  Actin inhibitor,DMSO,2840,Latrunculin B - actin poison
EI-181,Okadaic acid,805,6-A04,6,Plate 2,A04,EnzoICCB2,SP0130,A08,Okadaic acid - phosphatase inhibitor,ICCB Known Bioactives Library,0.124,Inhibitors:  PP1 PP2A inhibitor,DMSO,2840,Okadaic acid - phosphatase inhibitor
EI-216,AA-861,326.4,6-H04,6,Plate 2,H04,EnzoICCB2,SP0130,O08,AA-861 - lipoxygenase inhibitor,ICCB Known Bioactives Library,3.06,Lipid biosynthesis:  5-lipoxygenase inhibitor,DMSO,2840,AA-861 - lipoxygenase inhibitor
ST-330,D609,210.3,5-A03,5,Plate 1,A03,EnzoICCB2,SP0130,A05,D609 - phospholipase inhibitor,ICCB Known Bioactives Library,4.75,Lipid biosynthesis:  PC-PLC inhibitor,DMSO,2840,D609 - phospholipase inhibitor
S-109,1-Deoxymannojirimycin hydrochloride,199.6,5-A07,5,Plate 1,A07,EnzoICCB2,SP0130,A13,Deoxymannojirimycin(1) - glycoside hydrolase inhibitor,ICCB Known Bioactives Library,5.01,Inhibitors:  mannosidase inhibitor,DMSO,2840,Deoxymannojirimycin(1) - glycoside hydrolase inhibitor
EI-148,H7,291.4,5-D04,5,Plate 1,D04,EnzoICCB2,SP0130,G07,H7 - kinase inhibitor,ICCB Known Bioactives Library,3.43,Kinase inhibitors:  kinase inhibitor,DMSO,2840,H7 - kinase inhibitor
CA-420,2;5-Ditertbutylhydroquinone,222.3,5-B06,5,Plate 1,B06,EnzoICCB2,SP0130,C11,2;5-Ditertbutylhydroquinone - ER Ca++ ATPase inhibitor,ICCB Known Bioactives Library,4.5,Ion channel ligands:  ER Ca++ ATPase inhibitor,DMSO,2840,2;5-Ditertbutylhydroquinone - ER Ca++ ATPase inhibitor
FR-103,MCI-186,174.2,5-G09,5,Plate 1,G09,EnzoICCB2,SP0130,M17,MCI-186 - antioxidant,ICCB Known Bioactives Library,5.74,Inhibitors:  antioxidant; cytoprotectant,DMSO,2840,MCI-186 - antioxidant
CN-200,LY-83583,250.3,5-G04,5,Plate 1,G04,EnzoICCB2,SP0130,M07,LY-83583 - guanylate cyclase inhibitor,ICCB Known Bioactives Library,4,Inhibitors:  Inhibits NO-activation of guanylate cyclase ,DMSO,2840,LY-83583 - guanylate cyclase inhibitor
EI-309,NSC-95397,310.4,5-E09,5,Plate 1,E09,EnzoICCB2,SP0130,I17,NSC-95397 - phosphatase inhibitor,ICCB Known Bioactives Library,3.22,Inhibitors:  CDC25 phosphatase inhibitor,DMSO,2840,NSC-95397 - phosphatase inhibitor
EI-152,K252A,467.5,5-E11,5,Plate 1,E11,EnzoICCB2,SP0130,I21,K252A - kinase inhibitor,ICCB Known Bioactives Library,0.214,Kinase inhibitors:  Kinase inhibitor (Broad spectrum),DMSO,2840,K252A - kinase inhibitor
GR-230,24(S)-hydroxycholesterol,402.7,5-E04,5,Plate 1,E04,EnzoICCB2,SP0130,I07,24(S)-Hydroxycholesterol - steroid hormone,ICCB Known Bioactives Library,2.48,Nuclear receptor ligands:  LXR agonist,DMSO,2840,24(S)-Hydroxycholesterol - steroid hormone
GR-233,CITCO,436.7,6-B05,6,Plate 2,B05,EnzoICCB2,SP0130,C10,CITCO - Const. androstane receptor (CAR) agonist,ICCB Known Bioactives Library,2.29,Nuclear receptor ligands:  Const. androstane receptor (CAR) agonist,DMSO,2840,CITCO - Const. androstane receptor (CAR) agonist
AM-100,Cyclo [Arg-Gly-Asp-D-Phe-Val],574.6,6-C07,6,Plate 2,C07,EnzoICCB2,SP0130,E14,Cyclo [Arg-Gly-Asp-D-Phe-Val] - integrin inhibitor,ICCB Known Bioactives Library,1.74,Inhibitors:  integrin inhibitor,DMSO,2840,Cyclo [Arg-Gly-Asp-D-Phe-Val] - integrin inhibitor
CA-302,E6 berbamine,757.8,5-B10,5,Plate 1,B10,EnzoICCB2,SP0130,C19,E6 Berbamine - calmodulin inhibitor,ICCB Known Bioactives Library,1.32,Inhibitors:  calmodulin inhibitor,DMSO,2840,E6 Berbamine - calmodulin inhibitor
CN-255,Furoxan,187.2,5-F05,5,Plate 1,F05,EnzoICCB2,SP0130,K09,Furoxan - NO donor,ICCB Known Bioactives Library,5.34,Activators:  NO donor,DMSO,2840,Furoxan - NO donor
EI-300,GM6001,388.5,5-C11,5,Plate 1,C11,EnzoICCB2,SP0130,E21,GM6001 - protease inhibitor,ICCB Known Bioactives Library,2.57,Protease inhibitors:  broad spectrum MMP inhibitor ,DMSO,2840,GM6001 - protease inhibitor
EI-269,Go6976,378.4,5-D02,5,Plate 1,D02,EnzoICCB2,SP0130,G03,Go6976 - kinase inhibitor,ICCB Known Bioactives Library,2.64,Kinase inhibitors:  PKC inhibitor,DMSO,2840,Go6976 - kinase inhibitor
EI-273,HBDDE,338.3,5-D09,5,Plate 1,D09,EnzoICCB2,SP0130,G17,HBDDE - kinase inhibitor,ICCB Known Bioactives Library,2.96,Kinase inhibitors:  PKC inhibitor,DMSO,2840,HBDDE - kinase inhibitor
EI-248,HNMPA-(AM)3,454.4,5-D11,5,Plate 1,D11,EnzoICCB2,SP0130,G21,HNMPA-(AM)3 - kinase inhibitor,ICCB Known Bioactives Library,2.2,Kinase inhibitors:  Insulin receptor TK inhibitor,DMSO,2840,HNMPA-(AM)3 - kinase inhibitor
CC-207,Indirubin-3'-monoxime,277.3,6-D05,6,Plate 2,D05,EnzoICCB2,SP0130,G10,Indirubin-3'-monoxime - kinase inhibitor,ICCB Known Bioactives Library,3.61,Kinase inhibitors:  GSK-3beta inhibitor,DMSO,2840,Indirubin-3'-monoxime - kinase inhibitor
G-242,L-744;832,559.8,5-F04,5,Plate 1,F04,EnzoICCB2,SP0130,K07,L-744;832 - farnesylation inhibitor,ICCB Known Bioactives Library,1.79,Inhibitors:  Ras farnesyltransferase inhibitor,DMSO,2840,L-744;832 - farnesylation inhibitor
EI-295,LFM-A13,360,5-G11,5,Plate 1,G11,EnzoICCB2,SP0130,M21,LFM-A13 - kinase inhibitor,ICCB Known Bioactives Library,2.78,Kinase inhibitors:  BTK inhibitor,DMSO,2840,LFM-A13 - kinase inhibitor
FR-107,MnTBAP,879.1,5-B09,5,Plate 1,B09,EnzoICCB2,SP0130,C17,MnTBAP - antioxidant,ICCB Known Bioactives Library,1.14,Inhibitors:  SOD mimetic,DMSO,2840,MnTBAP - antioxidant
GR-322,Monastrol,292.4,5-H08,5,Plate 1,H08,EnzoICCB2,SP0130,O15,Monastrol - Eg5 inhibitor,ICCB Known Bioactives Library,3.42,Inhibitors:  Eg5 inhibitor,DMSO,2840,Monastrol - Eg5 inhibitor
CC-202,N9-Isopropylolomoucine,326.4,5-F08,5,Plate 1,F08,EnzoICCB2,SP0130,K15,N9-Isopropylolomoucine - kinase inhibitor,ICCB Known Bioactives Library,3.06,Kinase inhibitors:  CDC-2 kinase inhibitor,DMSO,2840,N9-Isopropylolomoucine - kinase inhibitor
ST-315,OBAA,428.6,6-A03,6,Plate 2,A03,EnzoICCB2,SP0130,A06,OBAA - phospholipase inhibitor,ICCB Known Bioactives Library,2.33,Inhibitors:  phospholipase A2 inhibitor,DMSO,2840,OBAA - phospholipase inhibitor
L-133,PCA 4248,361.5,6-A08,6,Plate 2,A08,EnzoICCB2,SP0130,A16,PCA 4248 - bioactive lipid,ICCB Known Bioactives Library,2.77,Bioactive lipids:  PAF antagonist,DMSO,2840,PCA 4248 - bioactive lipid
EI-275,PP1,281.4,6-B08,6,Plate 2,B08,EnzoICCB2,SP0130,C16,PP1 - kinase inhibitor,ICCB Known Bioactives Library,3.55,Protease inhibitors:  src family trosine kinase inhibitor,DMSO,2840,PP1 - kinase inhibitor
EI-297,PP2,301.8,6-D10,6,Plate 2,D10,EnzoICCB2,SP0130,G20,PP2 - kinase inhibitor,ICCB Known Bioactives Library,3.31,Kinase inhibitors:  Src family tyrosine kinase inhibitor,DMSO,2840,PP2 - kinase inhibitor
PR-110,RWJ-60475-(AM)3,620.3,6-D02,6,Plate 2,D02,EnzoICCB2,SP0130,G04,RWJ-60475-(AM)3 - phosphatase inhibitor,ICCB Known Bioactives Library,1.61,Inhibitors:  CD45 phosphatase inhibitor,DMSO,2840,RWJ-60475-(AM)3 - phosphatase inhibitor
EI-294,SB 202190,331.3,6-D04,6,Plate 2,D04,EnzoICCB2,SP0130,G08,SB 202190 - kinase inhibitor,ICCB Known Bioactives Library,3.02,Kinase inhibitors:  MAP kinase inhibitor,DMSO,2840,SB 202190 - kinase inhibitor
GR-331,Splitomycin,198.2,6-D09,6,Plate 2,D09,EnzoICCB2,SP0130,G18,Splitomycin - sir2p inhibitor,ICCB Known Bioactives Library,5.04,Inhibitors:  sir2p inhibitor,DMSO,2840,Splitomycin - sir2p inhibitor
EI-263,tyrphostin AG-126,215.2,6-F09,6,Plate 2,F09,EnzoICCB2,SP0130,K18,Tyrphostin AG-126 - kinase inhibitor,ICCB Known Bioactives Library,4.65,Kinase inhibitors:  tyrosine kinase inhibitor,DMSO,2840,Tyrphostin AG-126 - kinase inhibitor
EI-267,tyrphostin AG-825,397.5,6-F02,6,Plate 2,F02,EnzoICCB2,SP0130,K04,Tyrphostin AG-825 - kinase inhibitor,ICCB Known Bioactives Library,2.52,Kinase inhibitors:  HER-1;2 tyrosine kinase inhibitor,DMSO,2840,Tyrphostin AG-825 - kinase inhibitor
PR-113,Tyrphostin-8,170.2,5-F11,5,Plate 1,F11,EnzoICCB2,SP0130,K21,Tyrphostin-8 - calcineurin inhibitor,ICCB Known Bioactives Library,5.88,Inhibitors:  Calcineurin inhibitor,DMSO,2840,Tyrphostin-8 - calcineurin inhibitor
EI-282,U-0126,380.5,6-G03,6,Plate 2,G03,EnzoICCB2,SP0130,M06,U-0126 - kinase inhibitor,ICCB Known Bioactives Library,2.63,Kinase inhibitors:  MEK inhibitor,DMSO,2840,U-0126 - kinase inhibitor
T-126,Wiskostatin,426.1,6-H11,6,Plate 2,H11,EnzoICCB2,SP0130,O22,Wiskostatin - N-WASP inhibitor,ICCB Known Bioactives Library,2.35,Inhibitors:  N-WASP inhibitor,DMSO,2840,Wiskostatin - N-WASP inhibitor
CN-223,YC-1,304.3,5-A05,5,Plate 1,A05,EnzoICCB2,SP0130,A09,YC-1 - Hif-1 inhibitor,ICCB Known Bioactives Library,3.29,Activators:  GC stimulator /  Hif-1 alpha inhibitor ,DMSO,2840,YC-1 - Hif-1 inhibitor
ZW-9170,Z-Leu3-VS,551.7,6-G10,6,Plate 2,G10,EnzoICCB2,SP0130,M20,Z-Leu3-VS - protease inhibitor,ICCB Known Bioactives Library,1.81,Protease inhibitors:  Proteasome inhibitor,DMSO,2840,Z-Leu3-VS - protease inhibitor
EI-298,ZM336372,389.4,6-G11,6,Plate 2,G11,EnzoICCB2,SP0130,M22,ZM336372 - kinase inhibitor,ICCB Known Bioactives Library,2.57,Kinase inhibitors:  Raf inhibitor,DMSO,2840,ZM336372 - kinase inhibitor
P-416,zVAD-FMK,467.5,6-H02,6,Plate 2,H02,EnzoICCB2,SP0130,O04,Z-VAD-FMK - protease inhibitor,ICCB Known Bioactives Library,2.14,Protease inhibitors:  Caspase inhibitor (broad spectrum),DMSO,2840,Z-VAD-FMK - protease inhibitor
,,,,,Plate 1,A01,EnzoICCB2,SP0130,A01,DMSOA01,,,,,,DMSOA01
,,,,,Plate 1,B01,EnzoICCB2,SP0130,C01,DMSOC01,,,,,,DMSOC01
,,,,,Plate 1,C01,EnzoICCB2,SP0130,E01,DMSOE01,,,,,,DMSOE01
,,,,,Plate 1,D01,EnzoICCB2,SP0130,G01,DMSOG01,,,,,,DMSOG01
,,,,,Plate 1,E01,EnzoICCB2,SP0130,I01,DMSOI01,,,,,,DMSOI01
,,,,,Plate 1,F01,EnzoICCB2,SP0130,K01,DMSOK01,,,,,,DMSOK01
,,,,,Plate 1,G01,EnzoICCB2,SP0130,M01,DMSOM01,,,,,,DMSOM01
,,,,,Plate 1,H01,EnzoICCB2,SP0130,O01,DMSOO01,,,,,,DMSOO01
,,,,,Plate 4,A01,EnzoICCB2,SP0130,B02,DMSOB02,,,,,,DMSOB02
,,,,,Plate 4,B01,EnzoICCB2,SP0130,D02,DMSOD02,,,,,,DMSOD02
,,,,,Plate 4,C01,EnzoICCB2,SP0130,F02,DMSOF02,,,,,,DMSOF02
,,,,,Plate 4,D01,EnzoICCB2,SP0130,H02,DMSOH02,,,,,,DMSOH02
,,,,,Plate 4,E01,EnzoICCB2,SP0130,J02,DMSOJ02,,,,,,DMSOJ02
,,,,,Plate 4,F01,EnzoICCB2,SP0130,L02,DMSOL02,,,,,,DMSOL02
,,,,,Plate 4,G01,EnzoICCB2,SP0130,N02,DMSON02,,,,,,DMSON02
,,,,,Plate 4,H01,EnzoICCB2,SP0130,P02,DMSOP02,,,,,,DMSOP02
,,,,,Plate 1,A12,EnzoICCB2,SP0130,A23,DMSOA23,,,,,,DMSOA23
,,,,,Plate 1,B12,EnzoICCB2,SP0130,C23,DMSOC23,,,,,,DMSOC23
,,,,,Plate 1,C12,EnzoICCB2,SP0130,E23,DMSOE23,,,,,,DMSOE23
,,,,,Plate 1,D12,EnzoICCB2,SP0130,G23,DMSOG23,,,,,,DMSOG23
,,,,,Plate 1,E12,EnzoICCB2,SP0130,I23,DMSOI23,,,,,,DMSOI23
,,,,,Plate 1,F12,EnzoICCB2,SP0130,K23,DMSOK23,,,,,,DMSOK23
,,,,,Plate 1,G12,EnzoICCB2,SP0130,M23,DMSOM23,,,,,,DMSOM23
,,,,,Plate 1,H12,EnzoICCB2,SP0130,O23,DMSOO23,,,,,,DMSOO23
,,,,,Plate 4,A12,EnzoICCB2,SP0130,B24,DMSOB24,,,,,,DMSOB24
,,,,,Plate 4,B12,EnzoICCB2,SP0130,D24,DMSOD24,,,,,,DMSOD24
,,,,,Plate 4,C12,EnzoICCB2,SP0130,F24,DMSOF24,,,,,,DMSOF24
,,,,,Plate 4,D12,EnzoICCB2,SP0130,H24,DMSOH24,,,,,,DMSOH24
,,,,,Plate 4,E12,EnzoICCB2,SP0130,J24,DMSOJ24,,,,,,DMSOJ24
,,,,,Plate 4,F12,EnzoICCB2,SP0130,L24,DMSOL24,,,,,,DMSOL24
,,,,,Plate 4,G12,EnzoICCB2,SP0130,N24,DMSON24,,,,,,DMSON24
,,,,,Plate 4,H12,EnzoICCB2,SP0130,P24,DMSOP24,,,,,,DMSOP24
